🟢 Inovio Pharmaceuticals is trading 5.73% up today; reason remains unconfirmed

Inovio Pharmaceuticals is trading 5.73% up at $1.31; the reason remains unconfirmed.

• No clearly dated September 22, 2026 company-specific announcement or direct catalyst was identified.
• Recent coverage focuses on INO-3107’s FDA review and October 30 PDUFA target, reported before September 22.
• The Nasdaq Composite is up 0.48%, but that move is insufficient to establish a clear cause.